Scheena Williams
Psychiatric/Mental Health · Bedford, TXNPI 1467110486
Payments from drug & device makers
Across 345 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$864
- Alkermes, Inc.$848
- Corium, LLC$460
- AbbVie$421
- Teva Pharmaceuticals USA, Inc.$419
- Tris Pharma Inc$418
- plus $4K from 19 others
What the payments were for
- Food & beverage$6,958100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $864 |
| Alkermes, Inc. | 29 | $848 |
| Corium, LLC | 19 | $460 |
| AbbVie | 25 | $421 |
| Teva Pharmaceuticals USA, Inc. | 22 | $419 |
| Tris Pharma Inc | 6 | $418 |
| Lundbeck LLC | 31 | $399 |
| Otsuka America Pharmaceutical, Inc. | 25 | $398 |
| Axsome Therapeutics, Inc. | 13 | $365 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $334 |
| Johnson & Johnson | 21 | $315 |
| E.r. Squibb & Sons, L.L.C. | 20 | $260 |
| Neurocrine Biosciences, Inc. | 10 | $233 |
| Sunovion Pharmaceuticals Inc. | 14 | $205 |
| Vanda Pharmaceuticals Inc. | 8 | $158 |
| Jazz Pharmaceuticals Inc. | 3 | $156 |
| Supernus Pharmaceuticals, Inc. | 3 | $144 |
| Validus Pharmaceuticals LLC | 5 | $131 |
| Neos Therapeutics, LP | 10 | $117 |
| Bausch Health US, LLC | 7 | $92 |
| Ironshore Pharmaceuticals Inc. | 5 | $86 |
| Noven Therapeutics, LLC | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Orexo US, Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$400
- Quillivant$350
- Quillichew ER$350
- Dyanavel XR$350
- SUNOSI$127
- QELBREE$125
- Auvelity$108
- CAPLYTA$103
How this compares
$6,958 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lithium Carbonate | 14 | $215 |
| Lithium Carbonate ErLithium Carbonate | 13 | $183 |
| Buspirone Hcl | 12 | $182 |
| Quetiapine Fumarate | 16 | $178 |
| Alprazolam | 15 | $141 |
| Lorazepam | 13 | $21 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Bedford
- Christine WysongBedford$12K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.